ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 1 filers reported holding ELOXX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $25,000 | -35.9% | 145,381 | 0.0% | 0.00% | – |
| Q2 2022 | $39,000 | -52.4% | 145,381 | -0.6% | 0.00% | – |
| Q1 2022 | $82,000 | -20.4% | 146,291 | 0.0% | 0.00% | – |
| Q4 2021 | $103,000 | -16.9% | 146,291 | +92.2% | 0.00% | – |
| Q3 2021 | $124,000 | +416.7% | 76,122 | +537.6% | 0.00% | – |
| Q2 2021 | $24,000 | -89.9% | 11,939 | -83.3% | 0.00% | – |
| Q1 2021 | $237,000 | -16.8% | 71,282 | -0.4% | 0.00% | – |
| Q4 2020 | $285,000 | +44.7% | 71,568 | -4.5% | 0.00% | – |
| Q3 2020 | $197,000 | +0.5% | 74,979 | +15.6% | 0.00% | – |
| Q2 2020 | $196,000 | +46.3% | 64,842 | -5.5% | 0.00% | – |
| Q1 2020 | $134,000 | -73.5% | 68,651 | 0.0% | 0.00% | – |
| Q4 2019 | $505,000 | +74.1% | 68,651 | +7.0% | 0.00% | – |
| Q3 2019 | $290,000 | -53.5% | 64,185 | +2.6% | 0.00% | – |
| Q2 2019 | $624,000 | -23.7% | 62,572 | -10.6% | 0.00% | – |
| Q1 2019 | $818,000 | +1.5% | 70,008 | +4.3% | 0.00% | – |
| Q4 2018 | $806,000 | -25.3% | 67,111 | +6.0% | 0.00% | – |
| Q3 2018 | $1,079,000 | +3.9% | 63,311 | +4.1% | 0.00% | – |
| Q2 2018 | $1,038,000 | – | 60,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clal Insurance Enterprises Holdings Ltd | 14,626 | $27 | 0.00% |